Nektar Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.

About NKTR

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. 

CEO
Howard W. Robin
CEOHoward W. Robin
Employees
63
Employees63
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1990
Founded1990
Employees
63
Employees63

NKTR Key Statistics

Market cap
2.21B
Market cap2.21B
Price-Earnings ratio
-7.53
Price-Earnings ratio-7.53
Dividend yield
Dividend yield
Average volume
953.68K
Average volume953.68K
High today
$78.00
High today$78.00
Low today
$72.01
Low today$72.01
Open price
$73.55
Open price$73.55
Volume
552.48K
Volume552.48K
52 Week high
$78.81
52 Week high$78.81
52 Week low
$6.48
52 Week low$6.48

Stock Snapshot

As of today, Nektar Therapeutics(NKTR) shares are valued at $75.77. The company's market cap stands at 2.21B, with a P/E ratio of -7.53.

On 2026-04-03, Nektar Therapeutics(NKTR) stock moved within a range of $72.01 to $78.00. With shares now at $75.77, the stock is trading +5.2% above its intraday low and -2.9% below the session's peak.

Trading activity shows a volume of 552.48K, compared to an average daily volume of 953.68K.

Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $78.81 and a low of $6.48.

Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $78.81 and a low of $6.48.

NKTR News

Simply Wall St 16h
Assessing Nektar Therapeutics Valuation After A Sharp Multi‑Month Share Price Run

Advertisement Company overview and recent stock performance Nektar Therapeutics (NKTR) has drawn fresh attention after an extended run in its share price, wit...

Assessing Nektar Therapeutics Valuation After A Sharp Multi‑Month Share Price Run

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%

People also own

Based on the portfolios of people who own NKTR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.